Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
Can Merck Keytruda Crawl Back Above Bristol-Myers Opdivo?
Bidness, ETC
Sat, 12/19/15 - 11:36 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Bristol's drug pricing under fire as UK agency rejects Opdivo
Yahoo/Reuters
Wed, 12/16/15 - 10:07 am
Bristol-Myers Squibb
UK
Opdivo
NICE
Bristol-Myers Squibb's Opdivo May Change How We Treat Pancreatic Cancer
Motley Fool
Sun, 11/29/15 - 12:36 pm
Bristol-Myers Squibb
Opdivo
pancreatic cancer
FDA declines expanded approval for Bristol-Myers' Opdivo drug
Yahoo/Reuters
Fri, 11/27/15 - 05:48 pm
FDA
Bristol-Myers Squibb
Opdivo
melanoma
FDA approves expanded use of Bristol-Myers' skin cancer drug
Yahoo/Reuters
Tue, 11/24/15 - 01:52 pm
FDA
Bristol-Myers Squibb
melanoma
Opdivo
Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer
Motley Fool
Sun, 11/22/15 - 10:47 am
chemotherapy
cancer immunotherapies
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
targeted therapies
Pfizer
Xalkori
stem cells
OncoMed
tumor hypoxia
Threshold Pharmaceuticals
AbbVie's Humira repeats, joined by BMS' Opdivo in leading TV spending for October
Fierce Pharma Marketing
Wed, 11/18/15 - 09:42 am
AbbVie
Humira
Bristol-Myers Squibb
Opdivo
drug ads
Bristol-Myers nabs FDA priority review for new Opdivo use in kidney cancer
Fierce Pharma
Tue, 11/17/15 - 05:57 pm
Bristol-Myers Squibb
FDA
priority review
Opdivo
kidney cancer
Bristol-Myers Squibb turns to DTC to promote Opdivo
Medical Marketing and Media
Thu, 10/29/15 - 06:17 pm
Bristol-Myers Squibb
DTC
Opdivo
Merck's Keytruda has a shot at a bigger share of NSCLC sales
Fierce Pharma Marketing
Wed, 10/28/15 - 02:59 pm
Merck
Keytruda
non-small cell lung cancer
Opdivo
Bristol-Myers Squibb
Opdivo expansion may displace Keytruda
Medical Marketing and Media
Sat, 10/17/15 - 03:15 pm
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Bristol-Myers' Opdivo Gets Another Early Approval
Investors.com
Sun, 10/11/15 - 01:52 pm
Opdivo
Bristol-Myers Squibb
non-squamous lung cancer
FDA
Bristol-Myers' Opdivo Gets Another Early Approval
Investors.com
Sun, 10/11/15 - 01:52 pm
Opdivo
Bristol-Myers Squibb
non-squamous lung cancer
FDA
Keytruda's label confers edge for Opdivo
Medical Marketing and Media
Mon, 10/5/15 - 06:02 pm
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
PDL-1 inhibitors
Kidney Cancer Drug Boxing Match
Motley Fool
Mon, 10/5/15 - 09:17 am
kidney cancer
Bristol-Myers Squibb
Novartis
Exelixis
Opdivo
Cometriq
Afinitor
Bristol-Myers Cancer Drug Combination to Cost $256,000 a Year
Bloomberg
Thu, 10/1/15 - 02:16 pm
Bristol-Myers Squibb
Opdivo
Yervoy
drug pricing
melanoma
skin cancer
FDA approves Bristol-Myers drug combination for skin cancer
Yahoo/Reuters
Thu, 10/1/15 - 09:22 am
FDA
Bristol-Myers Squibb
skin cancer
Opdivo
Yervoy
Bristol-Myers, J&J Upgraded On New Drug Prospects
Investors.com
Tue, 09/29/15 - 10:27 pm
Bristol-Myers Squibb
JNJ
Imbruvica
Opdivo
daratumumab
Don't be quick to peg Merck's Keytruda in second place for NSCLC, analyst says
Fierce Pharma Marketing
Mon, 09/28/15 - 10:15 am
Merck
Keytruda
non-small cell lung cancer
Bristol-Myers Squibb
Opdivo
Why Opdivo Is Key for Bristol-Myers Squibb
Yahoo/Market Realist
Mon, 09/28/15 - 08:40 am
Opdivo
Bristol-Myers Squibb
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
next ›
last »